HOME >> MEDICINE >> NEWS
Overweight Hispanic youth face increased risk of diabetes, metabolic syndrome

Chevy Chase, MD, January 12, 2004 New research shows that large numbers of overweight Hispanic youth already have complications of obesity, including impaired glucose tolerance, which can lead to diabetes, and metabolic syndrome. The findings, which are published in the January issue of The Journal of Clinical Endocrinology & Metabolism (JCEM), indicate that Hispanic youth may have underlying risk factors that make them more susceptible to diabetes, cardiovascular risks and the metabolic syndrome.

Recent studies have shown that the metabolic syndrome--a collection of health risks such as obesity, dyslipidemia (characterized by high blood triglycerides and low HDL-cholesterol) and high blood pressure, which increase the chance of developing heart disease, stroke and diabetes--affects more than 20 percent of adults in the United States. Hispanics experience the highest rates of metabolic syndrome, with rates near 32 percent. During the past 10 years, the rate of obesity, which increases a person's risk of developing metabolic syndrome, has doubled among Hispanic youth. At the same time, the rates of type 2 diabetes and impaired glucose tolerance have also increased in this same group.

Dr. Michael Goran and researchers at the University of Southern California, Los Angeles, conducted two separate analysis on data collected in overweight Hispanic children to determine some of the risk factors that make these groups vulnerable to diabetes and associated conditions and diseases. In the first study, Dr. Goran and his colleagues studied the prevalence of metabolic syndrome and its individual components in Hispanic youth. They sought to understand the role of insulin sensitivity on metabolic syndrome and explored the relationships between the individual components of metabolic syndrome and insulin sensitivity.

"Obesity and the complications that are associated with this problem is a growing problem among minority children in the United States," e
'"/>

Contact: Marisa Lavine
mlavine@endo-society.org
301-941-0255
The Endocrine Society & The Hormone Foundation
12-Jan-2004


Page: 1 2 3 4

Related medicine news :

1. Overweight, boozy and depressed: Why we need healthy new years resolutions
2. Overweight men spend more on prescription drugs than normal-weight men
3. Overweight and obesity thresholds may be misleading for Asian populations
4. Overweight boys outweigh girls in stress response, study finds
5. Half-million cosmetic plastic surgery procedures for Hispanics in 2004 - up 49% from 2000
6. Chemistry and Flavor of Hispanic Foods one-day symposium, March 15
7. eDocAmerica launches Hispanic Website for members
8. English-speaking Hispanic youth more likely to have sex early
9. New study of African-American and Hispanic colorectal cancer patients
10. Black and Hispanic patients wait longer for heart attack treatment
11. Mexican Americans at greater risk for stroke than non-Hispanic whites

Post Your Comments:
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately held ... infections, microbial biofilms, and chronic wounds, announced that Dr. ... , Dr. Sinskey is a Professor ... of Technology, or MIT. He has been a member ... holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership ...
(Date:10/22/2014)... TUESDAY, Oct. 21, 2014 (HealthDay News) -- Two sisters ... and heart damage. Ilina and Medha Krishen use ... for sounds of trouble in breathing patterns or heartbeats. ... School in Michigan, wanted to find a way to ... air pollutants. Using an electronic stethoscope, Ilina recorded one ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... 20, 2014 The newly updated Worldwide ... of thousands of facts, figures and forecasts on the ... medical sector forecast categories the Worldwide Medical Market ... and national views on the worldwide medical market to ... report gives you data for 2010-2019, covering each country ...
(Date:10/20/2014)... October 20, 2014 The Advocator ... booth at the American Foundation for Suicide Prevention’s (AFSP) ... AFSP is a not-for-profit organization that hosts hundreds of ... from these events are used to help understand and ... and personal relationships as well. , The Advocator ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Teen Sisters Develop Ways to Measure Lung, Heart Damage 2Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3
(Date:10/22/2014)... October 22, 2014 Oramed ... a clinical-stage pharmaceutical company focused on the development ... top-line clinical results from its Phase IIa clinical ... capsules, to treat type 1 diabetes. The trial was ... under a U.S. Food and Drug Administration ...
(Date:10/22/2014)... Colo. , Oct. 22, 2014   Surefire ... of infusion systems designed to maximize targeted delivery of ... pleased to announce that oncologist John R. Daniels ... Comprehensive Cancer Center, and surgical oncologist Steven C. ... have joined the Company,s Scientific Advisory Board (SAB).    ...
(Date:10/22/2014)... NEW YORK , Oct. 22, 2014 ... and dermatology therapies. PV-10, its novel investigational drug for ... the potential for systemic side effects. Its oncology focus ... liver. Provectus has completed phase 2 trials of PV-10 ... as a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
Cached News: